Physician

George Baker Hubbard, MD

According to 2025 Medicare claims, George Hubbard, MD (NPI: 1740397520) practices ophthalmology in the Athens-Clarke County, GA market, with the plurality of this provider's patient population coming from Clarke, GA. This provider's primary affiliated billing organization is THE EMORY CLINIC INC (NPI: 1396798229; TIN: 582030692) and primary practice location at 30677-7304. Hubbard is affiliated with the Emory Healthcare Network Advantage (ACO ID: A4771), participating under the MSSP model.

Hubbard's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 410 traditional Medicare patients, billed 5,733 HCPCS/CPT codes, and received $606,577 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 163 prescription claims across 42 beneficiaries totaling $8,527 in drug costs, led by Ketorolac Tromethamine (Ketorolac Tromethamine). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $7,501 and ending at $8,527. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$489K$978K2015 Medicare payment: $978,359 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $841,991 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $861,466 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $802,138 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $809,056 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $767,352 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $875,441 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $797,001 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $636,382 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $606,577 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20156924,981$978,359
20166284,488$841,991
20176124,040$861,466
20185173,504$802,138
20195443,844$809,056
20204293,079$767,352
20214553,401$875,441
20224273,263$797,001
20233685,070$636,382
20244105,733$606,577

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$11K$22K2015 Drug cost: $7,501 (USD; Tot_Drug_Cst)2016 Drug cost: $19,331 (USD; Tot_Drug_Cst)2017 Drug cost: $21,349 (USD; Tot_Drug_Cst)2018 Drug cost: $10,688 (USD; Tot_Drug_Cst)2019 Drug cost: $14,491 (USD; Tot_Drug_Cst)2020 Drug cost: $20,357 (USD; Tot_Drug_Cst)2021 Drug cost: $22,426 (USD; Tot_Drug_Cst)2022 Drug cost: $13,158 (USD; Tot_Drug_Cst)2023 Drug cost: $5,362 (USD; Tot_Drug_Cst)2024 Drug cost: $8,527 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201560134$7,501
201660135$19,331
201759169$21,349
201875261$10,688
201990272$14,491
202096289$20,357
202176263$22,426
202270185$13,158
202339107$5,362
202442163$8,527

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg55561$654
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more5050$116
67028Injection of drug into eye110398$98
92014Established patient complete exam of visual system335624$88
92134Imaging of retina347644$29

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Ketorolac TromethamineKetorolac Tromethamine21465$1,148
Prednisolone AcetatePrednisolone Acetate291,102$969
Atropine SulfateAtropine Sulfate13457$549
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat332,133$476
Timolol MaleateTimolol Maleate16812$137

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for George Baker Hubbard, MD?

Tedicare shows public-source Medicare data for George Baker Hubbard, MD (NPI 1740397520), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does George Baker Hubbard, MD have ACO affiliation data?

George Baker Hubbard, MD is shown with ACO affiliation data for Emory Healthcare Network Advantage (MSSP, ACO ID A4771).

What billing organization is linked to George Baker Hubbard, MD?

George Baker Hubbard, MD is linked to THE EMORY CLINIC INC (billing NPI 1396798229) in the available physician profile data.

Does George Baker Hubbard, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.